Polar Asset Management Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-163,000	Closed	-$3.71M	–	798
2024 Q3	$3.71M	Buy	163,000 +53,100	+48%	+$868K	0.08%	243
2024 Q2	$1.43M	Sell	109,900 -1,500	-1%	-$20.8K	0.03%	362
2024 Q1	$1.95M	Sell	111,400 -48,300	-30%	-$936K	0.03%	364
2023 Q4	$3.48M	Buy	159,700 +83,100	+108%	+$1.31M	0.06%	279
2023 Q3	$1.18M	Buy	+76,600	New	+$1.46M	0.03%	437
2023 Q1	–	Sell	-204,600	Closed	-$5.98M	–	1168
2022 Q4	$5.98M	Sell	204,600 -106,200	-34%	-$2.45M	0.07%	378
2022 Q3	$6.38M	Buy	310,800 +251,100	+421%	+$4.51M	0.08%	394
2022 Q2	$691K	Hold	59,700	–	–	0.01%	784
2022 Q1	$1.1M	Hold	59,700	–	–	0.01%	678
2021 Q4	$1.18M	Hold	59,700	–	–	0.01%	689
2021 Q3	$982K	Buy	+59,700	New	+$876K	0.01%	686